Temporal discordance between graft-versus-leukemia and graft-versus-host responses: A strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity?

Truitt, 1995, Principles of graft versus leukemia reactivity, Biol Blood Marrow Transplant, 1, 61 Sullivan, 1989, Influence of acute and chronic graft versus host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia, Blood, 73, 1720, 10.1182/blood.V73.6.1720.1720 Horowitz, 1990, Graft-versus-leukemia reactions after bone marrow transplantation, Blood, 75, 555, 10.1182/blood.V75.3.555.555 Truitt, 1983, Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft versus leukemia activity in vitro, J Immunol, 131, 2050, 10.4049/jimmunol.131.4.2050 Falkenburg, 1999, Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes, Blood, 94, 1201, 10.1182/blood.V94.4.1201 Rezvani, 2003, Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation, Blood, 102, 2892, 10.1182/blood-2003-01-0150 Kloosterboer, 2004, Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells, Leukemia, 18, 798, 10.1038/sj.leu.2403297 Mutis, 1999, Feasibility of immunotherapy of relapsed leukemia with ex vivo generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens, Blood, 93, 2336, 10.1182/blood.V93.7.2336 Bonnet, 1999, CD8 (+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells, Proc Natl Acad Sci U S A, 96, 8639, 10.1073/pnas.96.15.8639 Marjit, 2003, Hematopoiesis-restricted minor histocompatibility antigens HA-1 or HA-2-specific T cells can induce complete remissions of relapsed leukemia, Proc Natl Acad Sci U S A, 100, 2742, 10.1073/pnas.0530192100 Michalek, 2003, Definitive separation of graft versus leukemia and graft versus host specific CD4+ T cells by virtue of their receptor beta loci sequences, Proc Natl Acad Sci U S A, 100, 1180, 10.1073/pnas.0337543100 Crough, 2002, Donor-derived b2a2-specific T cells for immunotherapy of patients with chronic myeloid leukemia, J Immunother, 25, 469, 10.1097/00002371-200211000-00003 Boranic, 1971, Time pattern of the antileukemic effect of graft-versus-host reaction in mice, Cancer Res, 31, 1140 Drobyski, 2003, Elimination of leukemia in the absence of lethal graft versus host disease, J Immunol, 170, 3046, 10.4049/jimmunol.170.6.3046 Burt, 2003, Herpes simplex thymidine kinase gene transduced donor lymphocyte infusions for relapsed hematologic malignancies following allogeneic hematopoietic stem cell transplantation, Exp Hematol, 31, 903, 10.1016/S0301-472X(03)00226-1 Hessner, 1994, Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia, Genet Anal Tech Appl, 11, 90, 10.1016/1050-3862(94)90045-0 Link, 1998, Adoptive immunotherapy for leukemia, Hum Gene Ther, 9, 115, 10.1089/hum.1998.9.1-115 Bonini, 1997, HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia, Science, 276, 1719, 10.1126/science.276.5319.1719 Berger, 2003, Pharmacologically regulated fas-mediated death of adoptively transferred T cells in a nonhuman primate model, Blood, 103, 1261, 10.1182/blood-2003-08-2908 Thomis, 2001, A fas-based suicide switch in human T cells for the treatment of graft versus host disease, Blood, 97, 1249, 10.1182/blood.V97.5.1249